-
Signature
-
/s/ Katherine A. Krebel, Attorney-in-Fact
-
Issuer symbol
-
DRS
-
Transactions as of
-
01 Apr 2025
-
Net transactions value
-
-$148,780
-
Form type
-
4
-
Filing time
-
03 Apr 2025, 16:26:39 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
DRS |
Common Stock |
Options Exercise |
$0 |
+3,237 |
+19% |
$0.000000 |
20,572 |
01 Apr 2025 |
Direct |
F1 |
| transaction |
DRS |
Common Stock |
Tax liability |
$41,482 |
-1,262 |
-6.1% |
$32.87 |
19,310 |
01 Apr 2025 |
Direct |
F2 |
| transaction |
DRS |
Common Stock |
Options Exercise |
$0 |
+2,517 |
+13% |
$0.000000 |
21,827 |
01 Apr 2025 |
Direct |
F3 |
| transaction |
DRS |
Common Stock |
Tax liability |
$38,885 |
-1,183 |
-5.4% |
$32.87 |
20,644 |
01 Apr 2025 |
Direct |
F2 |
| transaction |
DRS |
Common Stock |
Sale |
$68,413 |
-2,150 |
-10% |
$31.82 |
18,494 |
02 Apr 2025 |
Direct |
F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
DRS |
Restricted Stock Unit |
Options Exercise |
$0 |
-3,237 |
-23% |
$0.000000 |
10,790 |
01 Apr 2025 |
Common Stock |
3,237 |
|
Direct |
F1 |
| transaction |
DRS |
Restricted Stock Unit |
Options Exercise |
$0 |
-2,517 |
-23% |
$0.000000 |
8,273 |
01 Apr 2025 |
Common Stock |
2,517 |
|
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: